. ; .
.
TP53 gene deletions or mutations were related to more aggressiveness in invasive and in situ bladder tumors. However, its prognostic value in the superficial ones is not well defined. Sixty-two cases with low-grade superficial urothelial cell carcinomas (uccs) were studied. twenty-two suffered recurrence and 10 of these progressed. FiSH for TP53 detection and immunohistochemistry for p53 with both Do7 and Ab-24...
Financiadores do RCAAP | |||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |